News
4d
News Medical on MSNUnraveling NEMO: how a single gene shapes immune resilience and rare disease
A new study has traced the genetic roots of several rare and complex disorders to mutations in a single critical gene: IKBKG, ...
This meta-analysis provides preliminary evidence supporting the use of fecal microbiota transplantation (FMT) as a strategy ...
The cloud IT vendor said it now gives patients a no-login, digital identity-based access system to exercise greater control ...
Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in ...
Biomarkers at 6-week interim analysis show a positive impact on fibrogenesis, fibrolysis and potentially the initiation of a repair response The Independent Data Monitoring Committee (IDMC) has recomm ...
VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered ...
Objective Radiotherapy (RT) can cause a range of negative impacts in addition to the intended treatment impacts. Pulmonary rehabilitation (PR) may improve the physical and psychological conditions of ...
Medpace delivered a stunning Q2 2025, with double-digit revenue and net new awards growth. Click here to read why MEDP stock ...
Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), ...
Multidrug-resistant bacteria kill five million people each year, with newly resistant germs emerging faster than scientists ...
3d
Zacks.com on MSNCONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CONMED Corporation CNMD delivered second-quarter 2025 adjusted earnings per share (EPS) of $1.15, which beat the Zacks ...
3d
News-Medical.Net on MSNNovel insights from lymphoid structures: Lessons from colorectal cancer research
Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results